Aarti Surfactants Limited (AARTISURF)
₹498.85 +2.73% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Aarti Surfactants' revenue was ₹273 Cr (+26.4% year on year, +6.5% on the previous quarter), and net profit ₹9.0 Cr (+205.8% year on year); the operating margin was 7.4%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹273 | +26.4% | +6.5% |
| Operating profit | ₹20.3 | +74.5% | +53.6% |
| Net profit | ₹9.0 | +205.8% | +114.8% |
| EPS (₹) | 10.63 | +205.5% | +114.7% |
| Operating margin | 7.4% | — | — |
AARTISURF exchange data
NSE end-of-day data for
It closed at a price band (circuit) on 1 session in about the last 20.
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Aarti Surfactants Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate, issued by Registrar and Share Transfer Agent MUFG Intime India Private Limited on October 3, 2026, confirms that securities received for dematerialisation were processed, confirmed/rejected, and listed on the exchanges within prescribed timelines. This is a standard procedural filing with no operational or financial impact on the company.
- Compliance certificate submitted under Regulation 74(5) of SEBI Regulations, 2018
- Covers the quarter ended September 30, 2026
- Issued by RTA MUFG Intime India Private Limited dated October 3, 2026
- Confirms dematerialised shares were duly verified, mutilated, cancelled, and listed
Aarti Surfactants Limited has announced that its shareholders approved the alteration of the Main Object Clause (Clause 3, Sub-clause A) of its Memorandum of Association (MOA) during the 8th AGM on September 29, 2026. The approval was confirmed via the Scrutinizer report dated September 30, 2026. The amended clause broadens the scope of activities to explicitly cover pharmaceuticals, bulk drugs, agrochemicals, dyestuffs, and various specialty chemical formulations. The formal submission of the amended MOA remains subject to regulatory approvals.
- Shareholder approval received at the 8th AGM held on September 29, 2026
- Scrutinizer report confirming member approval finalized on September 30, 2026
- Substituted Clause 3A expands object scope across pharmaceuticals, bulk drugs, dyestuffs, and agrochemicals
- Company to submit altered MOA post-receipt of required regulatory approvals
At the 8th Annual General Meeting held on September 29, 2026, Aarti Surfactants' shareholders approved the re-appointment of Mr. Nikhil P. Desai as CEO & Managing Director and Mr. Santosh M. Kakade as Whole-time Director for 5-year terms effective August 20, 2027, to August 19, 2032. Additionally, shareholders approved the appointment of Prof. Vandana B. Patravale as an Independent Director for a 5-year term from August 22, 2026, to August 21, 2031. The decisions ensure continuity in executive leadership as the company executes its growth strategy, backed by a TTM revenue base of Rs 916 Cr.
- Re-appointment of Mr. Nikhil P. Desai as CEO & MD for 5 years effective August 20, 2027 to August 19, 2032
- Re-appointment of Mr. Santosh M. Kakade as Whole-time Director for 5 years from August 20, 2027 to August 19, 2032
- Appointment of Prof. Vandana B. Patravale as Independent Director for 5 years starting August 22, 2026
Aarti Surfactants shared its 8th Annual General Meeting presentation detailing annual FY26 performance and operational highlights. FY26 consolidated revenue rose 30% YoY to Rs 859.13 Cr, though net profit declined 15% to Rs 12.34 Cr due to margin pressures (EBITDA margin narrowed to 5.49% from 7.53%). Notably, CRISIL upgraded the company's long-term bank facilities rating to 'CRISIL A-/Stable' from 'CARE BBB+/Stable' in September 2026. The company maintained an 82% domestic and 18% export sales split across its 50+ product portfolio.
- FY26 consolidated revenue grew 30% YoY to Rs 85,912.92 Lakhs (Rs 859.13 Cr)
- Consolidated PAT decreased by 15% YoY to Rs 1,234.21 Lakhs (Rs 12.34 Cr), with PAT margin contracting to 1.43%
- Credit rating for long-term bank facilities upgraded to CRISIL A-/Stable from CARE BBB+/Stable in September 2026
- Sales mix stood at 82% domestic and 18% international across 50+ products and 100+ customers
Aarti Surfactants received an adverse order from the Commissioner of Customs (JNCH) concerning misclassification of imported goods. The order confirms differential duty demands totalling approximately ₹1.54 Cr (against which ₹2.25 Cr is already appropriated) and imposes a company penalty of ₹1.54 Cr, a ₹25 lakh redemption fine, and ₹20 lakh in personal penalties on the CEO & MD. The order also directs enforcement of a ₹2.76 Cr bond and ₹35 lakh bank guarantee. The company plans to contest the ruling by filing an appeal before the CESTAT.
- Confirmed differential duty demands of ₹11,10,373 and ₹1,42,87,031 under Section 28(4) of the Customs Act, 1962
- Penalty of ₹1,53,97,404 imposed on the company under Section 114A, plus ₹20,000,00 in total penalties on the CEO & MD
- Company already appropriated ₹2,25,31,731 towards differential duty and interest liabilities
- Confiscated 171.444 MTs of goods valued at ₹2,30,34,882 with an option of redemption fine of ₹25,00,000
- Directed enforcement of a ₹2,76,35,214 bond and ₹35,00,000 bank guarantee issued by Axis Bank
Aarti Surfactants has announced the resignation of Mrs. Nisha B. Shah (DIN: 10049176) from her position as Non-Executive Independent Director, effective close of business hours on September 11, 2026. The director cited additional time commitments as the reason for stepping down and confirmed there are no other material reasons. She held no directorships in any other listed entities at the time of her departure. The exit does not affect ongoing core operations or the company's financial profile.
- Resignation of Non-Executive Independent Director Mrs. Nisha B. Shah effective September 11, 2026
- Director confirmed no other material reasons exist beyond additional time commitments
- Holds zero directorships in other listed companies as of the date of resignation
Aarti Surfactants Limited has announced the resignation of Mrs. Nisha B. Shah (DIN: 10049176) as a Non-Executive Independent Director, effective at the close of business hours on September 11, 2026. The director cited additional personal time commitments that prevented her from dedicating sufficient time to board duties. She confirmed that there are no other material reasons for her departure and held no directorships in other listed companies. The board departure does not alter the company's financial or operational position.
- Resignation of Non-Executive Independent Director Mrs. Nisha B. Shah effective September 11, 2026
- Confirmation provided that no other material reasons exist besides additional time commitments
- Zero directorships held by the departing director in other listed entities as of cessation date
Aarti Surfactants Limited has announced the resignation of Mrs. Nisha B. Shah (DIN: 10049176) as Non-Executive Independent Director, effective close of business hours on September 11, 2026. The director cited additional personal time commitments as the reason for stepping down. She confirmed that there are no other material reasons for her departure, and she holds no other directorships in listed entities. The change is administrative and does not impact day-to-day operations or the company's Rs 916 Cr TTM revenue run-rate.
- Resignation effective from close of business hours on September 11, 2026
- Reason cited as additional time commitments hindering sufficient board focus
- Confirmation provided that no other material reasons exist for the resignation
- Directorship in other listed entities reported as zero
Aarti Surfactants Limited has issued the notice for its 8th Annual General Meeting scheduled for September 29, 2026, alongside its FY26 Annual Report. For FY26, the company reported revenue from operations of ₹859.13 crore (up 30.35% YoY from ₹659.09 crore) with an EBITDA of ₹47.32 crore (5.51% margin) and a standalone net profit of ₹12.68 crore. Standalone Basic EPS stood at ₹14.99 compared to ₹17.72 in FY25. The company confirmed capital commitments of ₹2.64 crore and contingent liabilities of ₹11.67 crore as of March 31, 2026.
- 8th Annual General Meeting scheduled to be held on September 29, 2026, via Video Conferencing.
- FY26 standalone revenue from operations rose 30.35% YoY to ₹85,912.92 Lakhs.
- Standalone FY26 EBITDA reported at ₹4,731.80 Lakhs with an EBITDA margin of 5.51%.
- Standalone Net Profit for FY26 stood at ₹1,267.83 Lakhs with Basic EPS of ₹14.99.
Aarti Surfactants has fixed Tuesday, September 22, 2026, as the record date for determining shareholder eligibility for its final dividend of Re 1 per equity share (10% on face value of Rs 10) for FY 2025-2026. The dividend is subject to approval at the upcoming Annual General Meeting on September 29, 2026. Upon approval, payment will be completed on or before October 27, 2026.
- Final dividend recommended at 10% (Re 1 per equity share of face value Rs 10)
- Record date fixed as Tuesday, September 22, 2026
- Shareholder approval scheduled for AGM on Tuesday, September 29, 2026
- Disbursement to be completed on or before Tuesday, October 27, 2026
Aarti Surfactants Limited has transitioned its credit rating agency from CARE Ratings to CRISIL Ratings Limited. CRISIL has upgraded the company's long-term bank loan facilities rating to 'CRISIL A-/Stable' from 'CARE BBB+; Stable'. The revised rating covers total bank loan facilities of Rs 200 Crore, reflecting improved credit profile and financial stability.
- Long-term bank loan facilities rating upgraded to 'CRISIL A-/Stable' from 'CARE BBB+; Stable'
- Total bank loan facilities rated stand at Rs 200 Crore
- Rated facilities include Rs 125 Crore fund-based limits, Rs 64.5 Crore term loan from HSBC, and Rs 10.5 Crore proposed facilities
- Agency transitioned from CARE Ratings Limited to CRISIL Ratings Limited on September 3, 2026
Aarti Surfactants Limited has incorporated a wholly owned subsidiary, Precision Ingredients USA Inc, in Wyoming, USA, with certificate of incorporation dated August 27, 2026. The new entity will handle marketing, import, export, and trading of surfactants, speciality chemicals, and allied products. Aarti Surfactants is subscribing to 10,000 shares at a par value of $1.00 each for a total cash consideration of $10,000. The setup aligns with the company's stated focus on expanding its export market share.
- 100% equity holding in newly incorporated subsidiary Precision Ingredients USA Inc in Wyoming, USA
- Incorporated on August 27, 2026, communicated to the company on August 31, 2026
- Total initial subscription cost of $10,000 (10,000 shares at $1.00 par value)
- Formed for marketing, import, export, and trading of surfactants and speciality chemicals
Aarti Surfactants Limited has approved the grant of 9,000 stock options to eligible employees under its 'ESOP 2024' scheme at a meeting held on August 24, 2026. Each option is exercisable into one equity share of face value Rs 10 at an exercise price of Rs 10 each. The options will vest in two equal tranches of 50% on the first and second anniversary of the grant date, subject to performance conditions. Exercisable window is 3 years from the date of respective vesting. Dilution impact from this grant is negligible.
- Granted 9,000 stock options under 'Aarti Surfactants Limited Employee Stock Option Plan 2024'
- Exercise price set at Rs 10 per option (equivalent to face value)
- Vesting schedule: 50% on the 1st anniversary and 50% on the 2nd anniversary
- Exercise period is 3 years from the respective vesting date
Aarti Surfactants' Board has approved the 5-year re-appointments of Mr. Nikhil P. Desai as CEO & Managing Director and Mr. Santosh M. Kakade as Executive Director, both effective from August 20, 2027, subject to shareholder approval. The Board also appointed Prof. Vandana B. Patravale as an Independent Director for a 5-year term starting August 22, 2026. Additionally, the company approved altering the Main Object Clause of its Memorandum of Association (MOA) to broaden business scope and promoted Mrs. Kanika Rathore to President – Business & Operations.
- Re-appointment of CEO & MD Nikhil P. Desai for a 5-year term from August 20, 2027 to August 19, 2032
- Re-appointment of Executive Director Santosh M. Kakade for a 5-year term from August 20, 2027 to August 19, 2032
- Appointment of Prof. Vandana B. Patravale as Non-Executive Independent Director for 5 years effective August 22, 2026
- Promotion of Mrs. Kanika Rathore to President – Business & Operations effective August 22, 2026
- Alteration of Main Object Clause of MOA approved, subject to shareholder vote at the AGM
Aarti Surfactants has completed the full redemption of 10,82,387 Non-Convertible Redeemable Preference Shares (NCRPS) upon their maturity on August 5, 2026. The total gross payout amounted to ₹23.23 Cr, representing approximately 9.4% of the company's net worth (₹246 Cr). The redemption was executed at ₹167.70 per share, which includes a face value of ₹10 and a premium of ₹157.70, plus a 4% annualized return for a seven-year period. This move clears the outstanding liability for this specific instrument (ISIN: INE09EO04017).
- Full redemption of 10,82,387 NCRPS completed on the maturity date of August 5, 2026.
- Total gross redemption amount paid stands at ₹23,23,40,864.
- Redemption price of ₹167.70 per share includes a significant premium of ₹157.70 over the ₹10 face value.
- Payment included an annualized return of 4% for a period of seven years as per original terms.
- Outstanding amount for this instrument is now Nil, reducing long-term financial obligations.
Financial Performance
Revenue Growth by Segment
Consolidated revenue from operations grew by 11.74% YoY, reaching INR 659.09 Cr in FY25 compared to INR 589.86 Cr in FY24. This growth was driven by a 7% increase in sales volumes and a 3% improvement in overall realizations, despite pricing pressures in the surfactants market.
Geographic Revenue Split
The company derives 80% of its revenue (INR 527.27 Cr) from the Domestic market and 20% (INR 131.82 Cr) from International sales as of FY25. This split highlights a strong reliance on the Indian FMCG sector while maintaining a significant export footprint.
Profitability Margins
Profitability witnessed a sharp decline; Net Profit Margin (PAT Margin) contracted from 3.62% in FY24 to 2.21% in FY25. This 141 bps compression occurred because the 11.7% revenue growth was offset by a 15.8% increase in total expenses, primarily driven by raw material cost inflation.
EBITDA Margin
Consolidated EBITDA margin declined significantly from 10.56% in FY24 to 7.53% in FY25. The core profitability was impacted by raw material costs rising to 82.8% of revenue in FY25 from 77.3% in FY24, as the company could not fully pass on the sharp spike in input costs to customers immediately.
Capital Expenditure
The company is undertaking a sizeable capital expenditure of INR 85 Cr spread over the next two years. This investment is targeted at capacity expansion at both the Pithampur and Silvassa manufacturing facilities to support future volume growth.
Credit Rating & Borrowing
The company's long-term bank facilities are rated CARE A-; Stable (upgraded from CARE BBB+). Finance costs decreased by 17.69% YoY to INR 11.55 Cr in FY25, reflecting improved debt management and a comfortable capital structure with an overall gearing of 0.47x.
Operational Drivers
Raw Materials
Specific raw materials include chemical intermediates for surfactants (such as fatty alcohols and ethylene oxide), which collectively accounted for 82.8% of total revenue in FY25, up from 77.3% in FY24.
Import Sources
Not specifically disclosed in available documents, though the company operates in international markets suggesting global sourcing for specialty chemical inputs.
Capacity Expansion
Current expansion involves an INR 85 Cr investment at Pithampur and Silvassa. The expansion is funded by INR 60 Cr of debt (of which INR 2 Cr is already availed) and INR 25 Cr from internal accruals/equity.
Raw Material Costs
Raw material costs rose to INR 541.84 Cr in FY25, representing 82.8% of revenue. This 21.5% YoY increase in absolute RM costs significantly outpaced revenue growth, leading to margin contraction.
Manufacturing Efficiency
Manufacturing efficiency is being targeted through economies of scale as volumes grew 7% YoY. However, the inventory turnover ratio declined from 1.36 to 1.32, indicating a slight slowdown in stock movement.
Strategic Growth
Expected Growth Rate
15-20%
Growth Strategy
Growth will be achieved through an INR 85 Cr capacity expansion, the addition of new MNC clients in the FMCG sector, and a shift toward higher-margin new product developments. Management has already implemented price increases to recover margins to the 7-10% EBITDA range.
Products & Services
The company sells surfactants and specialty chemicals used primarily by FMCG companies for home and personal care products like detergents, shampoos, and soaps.
Brand Portfolio
Aarti Surfactants Limited (operates primarily as a B2B supplier to major FMCG brands).
New Products/Services
New product development is focused on specialty surfactants; however, specific revenue contribution percentages for new launches are not yet disclosed.
Market Expansion
The company is targeting both domestic and international markets, with a focus on expanding its 20% export share through its integrated R&D framework.
Strategic Alliances
The company benefits from its association with the Aarti Group (Aarti Industries Limited), providing strong promoter backing and industry expertise.
External Factors
Industry Trends
The surfactants industry is evolving toward specialty and eco-friendly variants. Aarti Surfactants is positioning itself by investing in R&D and expanding capacity to meet the growing demand from the domestic FMCG sector, which is growing at a steady pace.
Competitive Landscape
Operates in a highly competitive surfactants segment with pressure from both domestic players and global chemical manufacturers.
Competitive Moat
The company's moat is built on its strong promoter pedigree (Aarti Group), long-standing relationships with global FMCG majors, and an integrated R&D framework. These advantages are sustainable due to high entry barriers in chemical manufacturing and strict quality approvals from MNC clients.
Macro Economic Sensitivity
Highly sensitive to global chemical commodity prices and domestic consumer spending in the FMCG sector. A 5% increase in RM costs without a corresponding price hike can reduce EBITDA margins by approximately 400-500 bps.
Consumer Behavior
Increased demand for personal hygiene and home care products post-pandemic continues to drive volume growth for the company's surfactant products.
Geopolitical Risks
Trade barriers or supply chain disruptions in chemical imports could impact the 82.8% RM cost base.
Regulatory & Governance
Industry Regulations
Operations are subject to chemical manufacturing standards and safety regulations. The company received an exceptional insurance claim of INR 4.20 Cr in FY25 related to a past fire incident at the Silvassa plant, highlighting the importance of safety compliance.
Environmental Compliance
The company operates manufacturing units in Pithampur and Silvassa, requiring adherence to strict environmental and pollution control norms, though specific ESG costs are not disclosed.
Taxation Policy Impact
The effective tax rate for FY25 was approximately 29% (INR 6.16 Cr tax on INR 21.15 Cr PBT).
Legal Contingencies
No major pending court cases or values disclosed, other than the settlement of insurance proceeds related to the 2022 Silvassa fire incident.
Risk Analysis
Key Uncertainties
The primary uncertainty is the volatility of raw material prices, which caused EBITDA margins to drop from 10.56% to 7.53% in one year. Sustained RM inflation could further impact cash accruals.
Geographic Concentration Risk
80% of revenue is concentrated in India, making the company highly dependent on the Indian monsoon and rural demand for FMCG products.
Third Party Dependencies
High dependency on raw material suppliers, as RM costs constitute 82.8% of the total revenue.
Technology Obsolescence Risk
Low risk of immediate obsolescence, but the company must continue R&D to keep pace with the shift toward green surfactants.
Credit & Counterparty Risk
Receivable turnover slowed to 2.12 in FY25, indicating a need for tighter credit monitoring of trade receivables which stood at an average of approximately INR 310 Cr.